Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Clinical trial NCT01366092 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01366092
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.